DAX-044

N/A

Report date: 2025/12/04 09:33:31

Base Information

Drug NameDAX-044
Drug Alias NameoNKo-044oNKo-044IL-12v-ABD-FcDAX-044
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-12 replacements
TargetsInterleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesoNKo-innate Pty Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesoNKo-innate Pty Ltd
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A